Beverly Teicher was named editor-in-chief of Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research. She officially began her term as editor-in-chief of Molecular Cancer Therapeutics on Jan. 1.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe